INDUSTRY × Observational × Endometrial Neoplasms × Clear all ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
Recruiting
50 enrolled
IREN
Recruiting
500 enrolled
DP-04
Recruiting
100 enrolled
DUOLife
Recruiting
150 enrolled
SMARAGD
Recruiting
1,975 enrolled
CAMPERR
Recruiting
7,000 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
HERGYN
Completed
509 enrolled
Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
Recruiting
3,000 enrolled
Development of a Molecular Diagnostic Tool for Endometrial Cancer.
Completed
1,950 enrolled
ORACLE
Recruiting
2,020 enrolled
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Terminated
19 enrolled
START
Terminated
10 enrolled
CYCLE_ENDO
Not yet recruiting
200 enrolled
BARHYSTER
Recruiting
132 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
INSPIRE
Recruiting
5,350 enrolled
Revealing Engagement Patterns Among Endometrial Cancer Patients
Not yet recruiting
500 enrolled
Evaluation of MCM5 in Postmenopausal Bleeding Patients
Unknown
2,000 enrolled
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Unknown
200 enrolled
Biomarkers for Gynecologic Cancer
Unknown
153 enrolled
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Completed
1,262 enrolled 14 charts